Cargando…
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849383/ https://www.ncbi.nlm.nih.gov/pubmed/35187405 http://dx.doi.org/10.1097/HS9.0000000000000686 |
| _version_ | 1784652452954374144 |
|---|---|
| author | Petzer, Verena Steiner, Normann Angelova-Unterberger, Olga Hetzenauer, Gabriele Philipp-Abbrederis, Kathrin Willenbacher, Ella Feistritzer, Clemens Willenbacher, Wolfgang Rudzki, Jakob Stauder, Reinhard Kocher, Florian Seeber, Andreas Pircher, Andreas Tymoszuk, Piotr Irsara, Christian Egger, Alexander Fux, Vilmos Anliker, Markus Gunsilius, Eberhard Nachbaur, David Schmidt, Stefan Wolf, Dominik |
| author_facet | Petzer, Verena Steiner, Normann Angelova-Unterberger, Olga Hetzenauer, Gabriele Philipp-Abbrederis, Kathrin Willenbacher, Ella Feistritzer, Clemens Willenbacher, Wolfgang Rudzki, Jakob Stauder, Reinhard Kocher, Florian Seeber, Andreas Pircher, Andreas Tymoszuk, Piotr Irsara, Christian Egger, Alexander Fux, Vilmos Anliker, Markus Gunsilius, Eberhard Nachbaur, David Schmidt, Stefan Wolf, Dominik |
| author_sort | Petzer, Verena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8849383 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88493832022-02-18 Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies Petzer, Verena Steiner, Normann Angelova-Unterberger, Olga Hetzenauer, Gabriele Philipp-Abbrederis, Kathrin Willenbacher, Ella Feistritzer, Clemens Willenbacher, Wolfgang Rudzki, Jakob Stauder, Reinhard Kocher, Florian Seeber, Andreas Pircher, Andreas Tymoszuk, Piotr Irsara, Christian Egger, Alexander Fux, Vilmos Anliker, Markus Gunsilius, Eberhard Nachbaur, David Schmidt, Stefan Wolf, Dominik Hemasphere Letter Lippincott Williams & Wilkins 2022-02-15 /pmc/articles/PMC8849383/ /pubmed/35187405 http://dx.doi.org/10.1097/HS9.0000000000000686 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-sa/4.0/This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) , which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Letter Petzer, Verena Steiner, Normann Angelova-Unterberger, Olga Hetzenauer, Gabriele Philipp-Abbrederis, Kathrin Willenbacher, Ella Feistritzer, Clemens Willenbacher, Wolfgang Rudzki, Jakob Stauder, Reinhard Kocher, Florian Seeber, Andreas Pircher, Andreas Tymoszuk, Piotr Irsara, Christian Egger, Alexander Fux, Vilmos Anliker, Markus Gunsilius, Eberhard Nachbaur, David Schmidt, Stefan Wolf, Dominik Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title | Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_full | Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_fullStr | Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_full_unstemmed | Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_short | Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies |
| title_sort | serologic responses to covid-19 vaccines in hematological patients are predominantly impaired in lymphoid but not in myeloid malignancies |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849383/ https://www.ncbi.nlm.nih.gov/pubmed/35187405 http://dx.doi.org/10.1097/HS9.0000000000000686 |
| work_keys_str_mv | AT petzerverena serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT steinernormann serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT angelovaunterbergerolga serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT hetzenauergabriele serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT philippabbrederiskathrin serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT willenbacherella serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT feistritzerclemens serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT willenbacherwolfgang serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT rudzkijakob serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT stauderreinhard serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT kocherflorian serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT seeberandreas serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT pircherandreas serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT tymoszukpiotr serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT irsarachristian serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT eggeralexander serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT fuxvilmos serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT anlikermarkus serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT gunsiliuseberhard serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT nachbaurdavid serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT schmidtstefan serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies AT wolfdominik serologicresponsestocovid19vaccinesinhematologicalpatientsarepredominantlyimpairedinlymphoidbutnotinmyeloidmalignancies |